Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)
- Conditions
- Dravet Syndrome
- Registration Number
- NCT04437004
- Lead Sponsor
- University of California, Los Angeles
- Brief Summary
The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
- Detailed Description
The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
Recruitment & Eligibility
- Status
- AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all available medications for seizures.
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of California, Los Angeles
🇺🇸Los Angeles, California, United States